ProfileGDS5678 / 1441139_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 59% 53% 53% 55% 53% 52% 56% 58% 52% 56% 52% 53% 53% 53% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5948459
GSM967853U87-EV human glioblastoma xenograft - Control 23.2932253
GSM967854U87-EV human glioblastoma xenograft - Control 33.2910953
GSM967855U87-EV human glioblastoma xenograft - Control 43.3169955
GSM967856U87-EV human glioblastoma xenograft - Control 53.2422253
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3612252
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5131156
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4852658
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2421852
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.3805656
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2730252
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2454853
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3009353
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2974853